Compared to dienogest, the GnRH analog was more efficient in controlling dysmenorrhea at 16 weeks (30.6 ± 18.4 vs. 0.0, p < 0.0001) but equally efficient at reducing dyspareunia and CPP. Here, GNRH1 is linked to Dysmenorrhea.